New drugs with antiprotozoal activity from marine Algae: A review

Revista Brasileira de Farmacognosia

Volumn 24, Issue 3, 2014, Pages 265-276

  Torres, Fábio A E ^a   Passalacqua, Thais G ^a   Velásquez, Angela M A ^a   de Souza, Rodrigo A ^a   Colepicolo, Pio ^b   Graminha, Márcia A S ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

African trypanosomiasis; Algae; Chagas disease; Drug discovery; Leishmaniasis; Natural products

Indexed keywords

EID: 84907314283     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjp.2014.07.001     Document Type: Short Survey

References (124)

1. Afonso, A.M., Ebell, M.H., Tarleton, R.L., 2012. A systematic review of high quality diagnostic tests for Chagas disease. Plos Neglect. Trop. D. 6, e1881 DOI: 10.1371/journal. pntd.0001881.
2. Allmendinger, A., Spavieri, J., Kaiser, M., Casey, R., Hingley-Wilson, S., Lalvani, A., Guiry, M., Blunden, G., Tasdemir, D., 2010. Antiprotozoal, antimycobacterial and cytotoxic potential of twenty-three british and irish red algae. Phytother. Res. 24, 1099-1103.
3. Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Canavate, C., Dedet, J.P., Gradoni, L., Ter Horst, R., Lopez-Velez, R., Moreno, J., 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin. Microbiol. Rev. 2, 334-359.
4. Aravindan, S., Delma, C.R., Thirugnanasambandan, S.S., Herman, T.S., Aravindan, N., 2013. Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae. Plos One 8, e61977 DOI: 10.1371/journal.pone.0061977.
5. Balasegaram, M., Ritmeijer, K., Lima, M.A., Burza, S., Genovese, G.O., Milani, B., Gaspani, S., Potet, J., Chappuis, F., 2012. Liposomal amphotericin B as a treatment for human leishmaniasis. Expert Opin. Emerg. Dr. 17, 493-510.
6. Barros-Alvarez, X., Gualdron-Lopez, M., Acosta, H., Caceres, A.J., Graminha, M.A., Michels, P.A., Concepcion, J.L., Quinones, W., 2013. Glycosomal targets for anti-trypanosomatid drug discovery. Curr. Med. Chem. 21, 1679-1706.
7. Berg, K., Zhai, L., Chen, M., Kharazmi, A., Owen, T.C., 1994. The use of a water-soluble formazam complex to quantitate the cell number and mitochrondrial-function of Leishmania major promastigotes. Parasitol. Res. 80, 235-239.
8. Berteau, O., Mulloy, B., 2003. Sulfated fucans, fresh perspectives: structures, functions, and biological properties of sulfated fucans and an overview of enzymes active toward this class of polysaccharide. Glycobiology 13, 29-40.
9. Bezerra, W.S., Meneguetti, D.U.O., Camargo, L.M.A., 2012. A busca de farmacos para tratamento da tripanossomiase americana: 103 anos de negligencia. Saude (Santa Maria) 38, 9-20.
10. Bhandari, V., Kulshrestha, A., Deep, D.K., Stark, O., Prajapati, V.K., Ramesh, V., Sundar, S., Schonian, G., Dujardin, J.C., Salotra, P., 2012. Drug susceptibility in leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. Plos Neglect. Trop. D. 6, e1657 DOI: 10.1371/journal.pntd.0001657.
11. Bianco, E.M., de Oliveira, S.Q., Rigotto, C., Tonini, M.L., Guimaraes, T.R., Bittencourt, F., Gouvea, L.P., Aresi, C., Rojo de Almeida, M.T., Goularte Moritz, M.I., Leal Martins, C.D., Scherner, F., Carraro, J.L., Horta, P.A., Reginatto, F.H., Steindel, M., Oliveira Simoes, C.M., Schenkel, E.P., 2013. Anti-infective potential of marine invertebrates and seaweeds from the brazilian coast. Molecules 18, 5761-5778.
12. Blunt, J.W., Copp, B.R., Keyzers, R.A., Munro, M.H., Prinsep, M.R., 2012. Marine natural products. Nat. Prod. Rep. 29, 144-222.
13. Blunt, J.W., Copp, B.R., Keyzers, R.A., Munro, M.H., Prinsep, M.R., 2013. Marine natural products. Nat. Prod. Rep. 30, 237-323.
14. Blunt, J.W., Copp, B.R., Munro, M.H.G., Northcote, P.T., Prinsep, M.R., 2011. Marine natural products. Nat. Prod. Rep. 28, 196-268.
15. Bolhassani, A., Taheri, T., Taslimi, Y., Zamanilui, S., Zahedifard, F., Seyed, N., Torkashvand, F., Vaziri, B., Rafati, S., 2011. Fluorescent Leishmania species: Development of stable GFP expression and its application for in vitro and in vivo studies. Exp. Parasitol. 127, 637-645.
16. Brun, R., Don, R., Jacobs, R.T., Wang, M.Z., Barrett, M.P., 2011. Development of novel drugs for human African trypanosomiasis. Future Microbiol. 6, 677-691.
17. Buckner, F.S., Verlinde, C.L., LaFlamme, A.C., VanVoorhis, W.C., 1996. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing betagalactosidase. Antimicrob. Agents Chemother. 40, 2592-2597.
18. Cabrita, M.T., Vale, C., Rauter, A.P., 2010. Halogenated compounds from marine algae. Mar. Drugs 8, 2301-2317.
19. Canavaci, A.M.C., Bustamante, J.M., Padilla, A.M., Brandan, C.M.P., Xu, D., Boehlke, C.L., Tarleton, R.L., 2010. In vitro and in vivo high-throughput assays for the testing of anti-Trypanosoma cruzi compounds. Plos Neglect. Trop. D. 4, e740 DOI: 10.1371/jornal.pntd.0000740.
20. Cardozo, K.H., Carvalho, V.M., Pinto, E., Colepicolo, P., 2006. Fragmentation of mycosporine-like amino acids by hydrogen/deuterium exchange and electrospray ionisation tandem mass spectrometry. Rapid Commun. Mass Sp. 20, 253-258.
21. Cardozo, K.H., Guaratini, T., Barros, M.P., Falcao, V.R., Tonon, A.P., Lopes, N.P., Campos, S., Torres, M.A., Souza, A.O., Colepicolo, P., Pinto, E., 2007. Metabolites from algae with economical impact. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 146, 60-78.
22. Chan-Bacab, M.J., Balanza, E., Deharo, E., Munoz, V., Garcia, R.D., Pena-Rodriguez, L.M., 2003. Variation of leishmanicidal activity in four populations of Urechites andrieuxii. J. Ethnopharmacol. 86, 243-247.
23. Cooper, R., Dragar, C., Elliot, K., Fitton, J.H., Godwin, J., Thompson, K., 2002. GFS, a preparation of Tasmanian Undaria pinnatifida is associated with healing and inhibition of reactivation of Herpes. BMC Complement. Altern. Med. 2, 11. DOI: 10.1186/1472-6882-2-11.
24. Coura, J.R., Borges-Pereira, J., 2012. Chagas disease. What is known and what should be improved: a systemic review. Rev. Soc. Bras. Med. Trop. 45, 286-296.
25. Croft, S.L., Olliaro, P., 2011. Leishmaniasis chemotherapychallenges and opportunities. Clin. Microbiol. Infec. 17, 1478-1483.
26. da Silva Machado, F.L., Pacienza-Lima, W., Rossi-Bergmann, B., de Souza Gestinari, L.M., Fujii, M.T., de Paula, J.C., Costa, S.S., Lopes, N.P., Kaiser, C.R., Soares, A.R., 2011. Antileishmanial sesquiterpenes from the brazilian red alga Laurencia dendroidea. Planta Med. 77, 733-735.
27. Davis, G.D.J., Vasanthi, A.H.R., 2011. Seaweed metabolite database (SWMD): A database of natural compounds from marine algae. Biomed. Informat. 5, 361-364.
28. de Felicio, R., de Albuquerque, S., Young, M.C., Yokoya, N.S., Debonsi, H.M., 2010. Trypanocidal, leishmanicidal and antifungal potential from marine red alga Bostrychia tenella J. Agardh (Rhodomelaceae, Ceramiales). J. Pharm. Biomed. Anal. 52, 763-769.
29. Den Boer, M., Argaw, D., Jannin, J., Alvar, J., 2011. Leishmaniasis impact and treatment access. Clin. Microbiol. Infec. 17, 1471-1477.
30. Desoti, V.C., Lazarin-Bidoia, D., Sudatti, D.B., Pereira, R.C., Alonso, A., Ueda-Nakamura, T., Dias Filho, B.P., Nakamura, C.V., Silva, S.O., 2012. Trypanocidal action of (-)-elatol involves an oxidative stress triggered by mitochondria dysfunction. Mar. Drugs 10, 1631-1646.
31. DNDi, 2013. Diseases and projects. Drugs for Neglected Diseases initiative, http://www.dndi.org/diseases-projects/diseases.html, accessed August 2013.
32. Dorlo, T.P.C., Balasegaram, M., Beijnen, J.H., de Vries, P.J., 2012. Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J. Antimicrob. Chemoth. 67, 2576-2597.
33. dos Santos, A.O., Britta, E.A., Bianco, E.M., Ueda-Nakamura, T., Filho, B.P., Pereira, R.C., Nakamura, C.V., 2011. 4-Acetoxydolastane diterpene from the Brazilian brown alga Canistrocarpus cervicornis as antileishmanial agent. Mar. Drugs 9, 2369-2383.
34. dos Santos, A.O., Veiga-Santos, P., Ueda-Nakamura, T., Sudatti, D.B., Bianco, E.M., Pereira, R.C., Nakamura, C.V., 2010. Effect of elatol, isolated from red seaweed Laurencia dendroidea, on Leishmania amazonensis. Mar. Drugs 8, 2733-2743.
35. dos Santos, V.A.F.F.M., Leite, K.M., Siqueira, M.C., Regasini, L.O., Martinez, I., Nogueira, C.T., Galuppo, M.K., Stolf, B.S., Soares Pereira, A.M., Cicarelli, R.M.B., Furlan, M., Graminha, M.A.S., 2013. Antiprotozoal activity of quinonemethide triterpenes from Maytenus ilicifolia (Celastraceae). Molecules 18 1053-1062.
36. Dumas, M., Girard, P.L., 1979. Sleeping Sickness. Trends Neurosci. 2, 256-258.
37. Filardi, L.S., Brener, Z., 1987. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. T. Roy. Soc. Trop. Med. H. 81, 755-759.
38. Fouladvand, M., Barazesh, A., Farokhzad, F., Malekizadeh, H., Sartavi, K., 2011. Evaluation of in vitro anti-leishmanial activity of some brown, green and red algae from the Persian Gulf. Eur. Rev. Med. Pharmacol. 15. 597-600.
39. Freile-Pelegrin, Y., Robledo, D., Chan-Bacab, M.J., Ortega-Morales, B.O., 2008. Antileishmanial properties of tropical marine algae extracts. Fitoterapia 79, 374-377.
40. Galle, J.B., Attioua, B., Kaiser, M., Rusig, A.M., Lobstein, A., Vonthron-Senecheau, C., 2013. Eleganolone, a diterpene from the French marine alga Bifurcaria bifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum. Mar. Drugs 11, 599-610.
41. Goto, H., Lindoso, J.A., 2010. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev. Anti-Infe. 8, 419-433.
42. Goto, H., Lindoso, J.A., 2012. Cutaneous and mucocutaneous leishmaniasis. Infect. Dis. Clin. N. Am. 26, 293-307.
43. Gressler, V., Stein, E.M., Dorr, F., Fujii, M.T., Colepicolo, P., Pinto, E., 2011. Sesquiterpenes from the essential oil of Laurencia dendroidea (Ceramiales, Rhodophyta): isolation, biological activities and distribution among seaweeds. Rev. Bras. Farmacogn. 21, 248-254.
44. Gressler, V., Yokoya, N.S., Fujii, M.T., Colepicolo, P., Mancini Filho, J., Torres, R.P., Pinto, E., 2010. Lipid, fatty acid, protein, amino acid and ash contents in four Brazilian red algae species. Food Chem. 120, 585-590.
45. Guaratini, T., Gates, P.J., Pinto, E., Colepicolo, P., Lopes, N.P., 2007. Differential ionisation of natural antioxidant polyenes in electrospray and nanospray mass spectrometry. Rapid Commun. Mass. Sp. 21, 3842-3848.
46. Gurib-Fakim, A., 2006. Medicinal plants: traditions of yesterday and drugs of tomorrow. Mol. Aspects Med. 27, 1-93.
47. Halberstein, R.A., 2005. Medicinal plants: historical and crosscultural usage patterns. Ann. Epidemiol. 15, 686-699.
48. Hayashi, K., Nakano, T., Hashimoto, M., Kanekiyo, K., Hayashi, T., 2008. Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int. Immunopharmacol. 8, 109-116.
49. Hidari, K.I., Takahashi, N., Arihara, M., Nagaoka, M., Morita, K., Suzuki, T., 2008. Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem. Bioph. Res. Co. 376, 91-95.
50. Hollnagel, H.C., Di Mascio, P., Asano, C.S., Okamoto, O.K., Stringher, C.G., Oliveira, M.C., Colepicolo, P., 1996. The effect of light on the biosynthesis of b-carotene and superoxide dismutase activity in the photosynthetic alga Gonyaulax polyedra. Braz. J. Med. Biol. Res. 29, 105-111.
51. Iten, M., Mett, H., Evans, A., Enyaru, J.C., Brun, R., Kaminsky, R., 1997. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine. Antimicrob. Agents Chemother. 41, 1922-1925.
52. Izumi, E., Ueda-Nakamura, T., Veiga, V.F. Jr, Pinto, A.C., Nakamura, C.V., 2012. Terpenes from Copaifera demonstrated in vitro antiparasitic and synergic activity. J. Med. Chem. 55, 2994-3001.
53. Jacobs, R.T., Nare, B., Phillips, M.A., 2011. State of the art in African trypanosome drug discovery. Curr. Top. Med. Chem. 11, 1255-1274.
54. Juffrie, M., Rosalina, I., Damayanti, W., Djumhana, A., Ariani, A., Ahmad, H., 2006. The efficacy of fucoidan on gastric ulcer. J. Gastroen. Hepatol. 11, 908-913.
55. Kang, J.W., 1968. Illustrated Encyclopedia of Fauna and Flora of Korea: Marine Algae. Seoul: Samhwa Press, p. 465, apud J. Ethonopharmacol. 116, 187-190, 2008.
56. Kar, S., Sharma, G., Das, P.K., 2011. Fucoidan cures infection with both antimony-susceptible and-resistant strains of Leishmania donovani through Th1 response and macrophage-derived oxidants. J. Antimicrob. Chemoth. 66, 618-625.
57. Kennedy, P.G.E., 2008. The continuing problem of human African trypanosomiasis (sleeping sickness). Ann. Neurol. 64, 116-126.
58. Kladi, M., Vagias, C., Stavri, M., Rahman, M.M., Gibbons, S., Roussis, V., 2008. C-15 acetogenins with antistaphylococcal activity from the red alga Laurencia glandulifera. Phytochem. Lett. 1, 31-36.
59. Leitao, M.A., Cardozo, K.H., Pinto, E., Colepicolo, P., 2003. PCB-induced oxidative stress in the unicellular marine dinoflagellate Lingulodinium polyedrum. Arch. Environ. Con. Tox. 45, 59-65.
60. Li, B., Lu, F., Wei, X., Zhao, R., 2008. Fucoidan: structure and bioactivity. Molecules 13, 1671-1695.
61. Liu, L., Heinrich, M., Myers, S., Dworjanyn, S.A., 2012. Towards a better understanding of medicinal uses of the brown seaweed Sargassum in Traditional Chinese Medicine: A phytochemical and pharmacological review. J. Ethnopharmacol. 142, 591-619.
62. Lopes, P.F., de Cabral Oliveira, M., Colepicolo, P., 2002. Characterization and daily variation of nitrate reductase in Gracilaria tenuistipitata (Rhodophyta). Biochem. Bioph. Res. Co. 295, 50-54.
63. Lutay, N., Nilsson, I., Wadstrom, T., Ljungh, A., 2011. Effect of heparin, fucoidan and other polysaccharides on adhesion of enterohepatic Helicobacter species to murine macrophages. Appl. Biochem. Biotech. 164, 1-9.
64. MacLean, L., Reiber, H., Kennedy, P.G.E., Sternberg, J.M., 2012. Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response. Plos Neglect. Trop. D. 6, e1857 DOI: 10.1371/journal.pntd.0001857.
65. Makarenkova, I.D., Deriabin, P.G., L'Vov, D.K., Zviagintseva, T.N., Besednova, N.N., 2010. Antiviral activity of sulfated polysaccharide from the brown algae Laminaria japonica against avian influenza A (H5N1) virus infection in the cultured cells. Vop. Virusol. 55, 41-45.
66. Maltezou, H.C., 2010. Drug resistance in visceral leishmaniasis. J Biomed Biotechnol. DOI: 10.1155/2010/617521.
67. Manriquez, C.P., Souto, M.L., Gavin, J.A., Norte, M., Fernandez, J.J., 2001. Several new squalene-derived triterpenes from Laurencia. Tetrahedron 57, 3117-3123.
68. Mayer, A.M.S., Rodriguez, A.D., Taglialatela-Scafati, O., Fusetani, N., 2013. Marine pharmacology in 2009-2011: marine compounds with antibacterial, antidiabetic, antifungal, antiinflammatory, antiprotozoal, antituberculosis, and antiviral activities; affecting the immune and nervous systems, and other miscellaneous mechanisms of action. Mar. Drugs 11, 2510-2573.
69. Mendes, L.F., Vale, L.A.S., Martins, A.P., Yokoya, N.S., Marinho-Soriano, E., Colepicolo, P., 2012. Influence of temperature, light and nutrients on the growth rates of the macroalga Gracilaria domingensis in synthetic seawater using experimental design. J. Appl. Phycol. 24, 1419-1426.
70. Mendonca, V.J., Silva, M.T., de Araujo, R., Martins-Junior, J., Bacci-Junior, M., Almeida, C.E., Costa, J., Graminha, M.A.S., Cicareli, R.M.B., Rosa, J.A., 2009. Philogeny of Triatoma sherlocki (Hemiptera: Reduviidae: Triatominae) inferred from two mitochondrial genes suggests its location within Triatoma brasiliensis complex. Am. J. Trop. Med. Hyg, 81, 858-864.
71. Moo-Puc, R., Robledo, D., Freile-Pelegrin, Y., 2008. Evaluation of selected tropical seaweeds for in vitro anti-trichomonal activity. J. Ethnopharmacol. 120, 92-97.
72. MS, 2011. Manual de recomendacoes para diagnostico, tratamento e acompanhamento de pacientes com a coinfeccao Leishmania-HIV/Ministerio da Saude, Secretaria de Vigilancia em Saude, Departamento de Vigilancia Epidemiologica, Ministerio da Saude, 106 p. http://portal.saude.gov.br/portal/arquivos/pdf/leishmania_hiv_web_25_01_11.pdf, accessed December, 2013.
73. MSF, 2008. Relatório anual 2008. Medicina Sem Fronteiras, https://www.msf.org.br/arquivos/Doc/Publicacoes/83.pdf, accessed November 2013.
74. Murta, S.M.F., Romanha, A.J., 1998. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116, 165-171.
75. Nara, T., Kamei, Y., Tsubouchi, A., Annoura, T., Hirota, K., Iizumi, K., Dohmoto, Y., Ono, T., Aoki, T., 2005. Inhibitory action of marine algae extracts on the Trypanosoma cruzi dihydroorotate dehydrogenase activity and on the protozoan growth in mammalian cells. Parasitol. Int. 54, 59-64.
76. Newman, D.J., Cragg, G.M., 2004. Marine natural products and related compounds in clinical and advanced preclinical trials. J. Nat. Prod. 67, 1216-1238.
77. Newman, D.J., Cragg, G.M., 2012. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311-335.
78. Nitta, I., Watase, H., Tomiie, Y., 1958. Structure of kainic acid and its isomer, allokainic acid. Nature 181, 761-762.
79. Orhan, I., Sener, B., Atici, T., Brun, R., Perozzo, R., Tasdemir, D., 2006. Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis. Phytomedicine 13, 388-393.
80. Ortalo-Magne, A., Culioli, G., Valls, R., Pucci, B., Piovetti, L., 2005. Polar acyclic diterpenoids from Bifurcaria bifurcata (Fucales, Phaeophyta). Phytochemistry 66, 2316-2323.
81. Pereira, H.S., Leao-Ferreira, L.R., Moussatche, N., Teixeira, V.L., Cavalcanti, D.N., Costa, L.J., Diaz, R., Frugulhetti, I., 2004. Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1). Antivir. Res. 64, 69-76.
82. Pinto, M.C., Barbieri, K., Silva, M.C.E., Graminha, M.A.S., Casanova, C., Andrade, A.J., Eiras, A.E., 2011. Octenol as attractant to Nyssomyia neivai (Diptera: Psychodidae: Phlebotominae) in the field. J. Med. Entomol. 48, 39-44.
83. Prata, A., 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 1, 92-100.
84. Ribeiro, I., Sevcsik, A.M., Alves, F., Diap, G., Don, R., Harhay, M.O., Chang, S., Pecoul, B., 2009. New, improved treatments for Chagas disease: from the R&D pipeline to the patients. Plos Neglec. Trop. D. 3, e484 DOI: 10.1371/jornal. pntd.0000484.
85. Romanha, A.J., Castro, S.L., Soeiro, Md.N., Lannes-Vieira, J., Ribeiro, I., Talvani, A., Bourdin, B., Blum B, Olivieri, B., Zani, C., Spadafora, C., Chiari, E., Chatelain, E., Chaves, G., Calzada, J.E., Bustamante, J.M., Freitas-Junior, L.H., Romero, L.I., Bahia, M.T., Lotrowska, M., Soares, M., Andrade, S.G., Armstrong, T., Degrave, W., Andrade, Z.D.A., 2010. In vitro and in vivo experimental models for drug screening and development for Chagas disease. Mem. I. Oswaldo Cruz 105, 233-238.
86. Sabina, H., Tasneem, S., Sambreen Kausar, Y., Choudhary, M.I., Aliya, R., 2005. Antileishmanial activity in the crude extract of various seaweed from the coast of Karachi, Pakistan. Pak. J. Bot. 37, 163-168.
87. Santos, V.A., Regasini, L.O., Nogueira, C.R., Passerini, G.D., Martinez, I., Bolzani, V.S., Graminha, M.A., Cicarelli, R.M., Furlan, M., 2012. Antiprotozoal sesquiterpene pyridine alkaloids from Maytenus ilicifolia. J. Nat. Prod. 75, 991-995.
88. Schaeffer, D.J., Krylov, V.S., 2000. Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotox. Environ. Safe. 45, 208-227.
89. Sereno, D., da Silva, A.C., Mathieu-Daude, F., Ouaissi, A., 2007. Advances and perspectives in Leishmania cell based drugscreening procedures. Parasitol. Int. 56, 3-7.
90. Sereno, D., Lemesre, J.L., 1997. In vitro life cycle of pentamidineresistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced. Antimicrob. Agents Chemother. 41, 1898-1903.
91. Shaw, J., Laison, R., Fraiha, H., 1969. Consideracoes sobre a epidemiologia dos primeiros casos autoctones de doenca de Chagas registrados em Belem, Para, Brasil. Rev. Saude Publ. 2, 153-157.
92. Shikanai-Yasuda, M.A., Carvalho, N.B., 2012. Oral transmission of Chagas disease. Clin. Infect. Dis. 54, 845-852.
93. Simarro, P.P., Diarra, A., Postigo, J.A.R., Franco, J.R., Jannin, J.G., 2011. The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: The way forward. Plos Neglect. Trop. D. 5, e1007 DOI:10.1371/journal.pntd.0001007.
94. Singh, N., Kumar, M., Singh, R.K., 2012. Leishmaniasis: Current status of available drugs and new potential drug targets. Asian Pac. J. Trop. Med. 5, 485-497.
95. Singh, S., Sivakumar, R., 2004. Challenges and new discoveries in the treatment of leishmaniasis. J. Infect. Chemother. 10, 307-315.
96. Soares, D.C., Calegari-Silva, T.C., Lopes, U.G., Teixeira, V.L., de Palmer Paixao, I.C.N., Cirne-Santos, C., Bou-Habib, D.C., Saraiva, E.M., 2012. Dolabelladienetriol, a compound from Dictyota pfaffii algae, inhibits the infection by Leishmania amazonensis. Plos Neglect. Trop. D. 6, e1787 DOI: 10.1371/journal.pntd.0001787.
97. Spavieri, J., Allmendinger, A., Kaiser, M., Casey, R., Hingley-Wilson, S., Lalvani, A., Guiry, M.D., Blunden, G., Tasdemir, D., 2010a. Antimycobacterial, antiprotozoal and cytotoxic potential of twenty-one brown algae (Phaeophyceae) from British and Irish waters. Phytother. Res. 24, 1724-1729.
98. Spavieri, J., Kaiser, M., Casey, R., Hingley-Wilson, S., Lalvani, A., Blunden, G., Tasdemir, D., 2010b. Antiprotozoal, antimycobacterial and cytotoxic potential of some british green algae. Phytother. Res. 24, 1095-1098.
99. Stein, E.M., Andreguetti, D.X., Rocha, C.S., Fujii, M.T., Baptista, M.S., Colepicolo, P., Indig, G.L., 2011. Search for cytotoxic agents in multiple Laurencia complex seaweed species (Ceramiales, Rhodophyta) harvested from the Atlantic Ocean with emphasis on the Brazilian State of Espirito Santo. Rev. Bras. Farmacogn. 21, 239-243.
100. Sundar, S., 2001. Drug resistance in Indian visceral leishmaniasis. Trop. Med. Int. Health 6, 849-854.
101. Sundar, S., Rai, M., 2002. Advances in the treatment of leishmaniasis. Curr. Opin. Infect. Dis. 15, 593-598.
102. Suzgec-Selcuk, S., Mericli, A.H., Guven, K.C., Kaiser, M., Casey, R., Hingley-Wilson, S., Lalvani, A., Tasdemir, D., 2011. Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities. Phytother. Res. 25, 778-783.
103. Sykes, M.L., Avery, V.M., 2013. Approaches to protozoan drug discovery: phenotypic screening. J. Med. Chem. 56, 7727-7740.
104. Sykes, M.L., Baell, J.B., Kaiser, M., Chatelain, E., Moawad, S.R., Ganame, D., Ioset, J.R., Avery, V.M., 2012. Identification of compounds with anti-proliferative activity against Trypanosoma brucei brucei strain 427 by a whole cell viability based HTS campaign. Plos Neglect. Trop. D. 6, e1896 DOI: 10.1371/journal.pntd.0001896.
105. Tanaka, Y., Okuda, M., Sonoda, M., 1975. Effect of chlorella on levels of cholesterol and triglyceride in liver and serum. Artery 4, 339-339.
106. Taoda, N., Shinji, E., Nishi, K., Nishioka, S., Yonezawa, Y., Uematsu, J., Hattori, E., Yamamoto, H., Kawano, M., Tsurudome, M., O'Brien, M., Yamashita, T., Komada, H., 2008. Fucoidan inhibits parainfluenza virus type 2 infection to LLCMK2 cells. Biomed. Res-Tokyo 29, 331-334.
107. Tempone, A.G., Martins de Oliveira, C., Berlink, R.G., 2011. Current approaches to discover marine antileishmanial natural products. Planta Med. 77, 572-585.
108. The Global Marine Pharmaceutical Pipeline. http://marinepharmacology.midwestern.edu/, access in December 2013.
109. Thompson, K.D., Dragar, C., 2004. Antiviral activity of Undaria pinnatifida against herpes simplex virus. Phytother. Res. 18, 551-555.
110. Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., Ford, N., 2002. Drug development for neglected diseases: a deficient market and a public-health policy failure. Lancet 359, 2188-2194.
111. Urbina, J.A., Docampo, R., 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19, 495-501.
112. van Griensven, J., Diro, E., 2012. Visceral leishmaniasis. Infect. Dis. Clin. N. Am. 26, 309-322.
113. Veiga-Santos, P., Pelizzaro-Rocha, K.J., Santos, A.O., Ueda-Nakamura, T., Dias Filho, B.P., Silva, S.O., Sudatti, D.B., Bianco, E.M., Pereira, R.C., Nakamura, C.V., 2010. In vitro antitrypanosomal activity of elatol isolated from red seaweed Laurencia dendroidea. Parasitology 137, 1661-1670.
114. Vonthron-Senecheau, C., Kaiser, M., Devambez, I., Vastel, A., Mussio, I., Rusig, A.M., 2011. Antiprotozoal activities of organic extracts from French marine seaweeds. Mar. Drugs 9, 922-933.
115. Werneck, G.L., 2010. Expansao geografica da leishmaniose visceral no Brasil. Cad. Saude Publica 26, 644-645.
116. Werneck, G.L., Hasselmann, M.H., Gouvea, T.G., 2011. An overview of studies on nutrition and neglected diseases in Brazil. Cienc. Saude Coletiva 16, 39-62.
117. WHO, 2003. How to develop and implement a national drug policy. World Health Organization, http://apps.who.int/medicinedocs/pdf/s4869e/s4869e.pdf, accessed August 2013.
118. WHO, 2010a. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. World Health Organization, http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf, accessed August 2013.
119. WHO, 2010b. Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases. World Health Organization, Geneva, Swiss.
120. WHO, 2013a. Why are some tropical diseases called "neglected"?. World Health Organization, http://www.who.int/features/qa/58/en/, accessed December 2013.
121. WHO, 2013b. Leishmaniasis. World Health Organization, http://www.who.int/leishmaniasis/en/index.html, accessed December 2013.
122. WHO, 2013c. Chagas disease (American trypanosomiasis). World Health Organization, http://www.who.int/mediacentre/factsheets/fs340/en/, accessed December 2013.
123. WHO, 2013d. Trypanosomiasis, Human African (sleeping sickness). World Health Organization, http://www.who.int/mediacentre/factsheets/fs259/en/, accessed December 2013.
124. Yamey, G., Torreele, E., 2002. The world's most neglected diseases. Brit. Med. J. 325, 176-177.